HCA Healthcare Inc (NYSE: HCA) kicked off on Tuesday, up 0.96% from the previous trading day, before settling in for the closing price of $363.16. Over the past 52 weeks, HCA has traded in a range of $226.44-$417.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 6.95% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 16.36%. With a float of $182.21 million, this company’s outstanding shares have now reached $265.54 million.
In an organization with 310000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 50.04%, operating margin of 15.08%, and the pretax margin is 12.55%.
HCA Healthcare Inc (HCA) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Care Facilities Industry. The insider ownership of HCA Healthcare Inc is 28.06%, while institutional ownership is 66.48%. The most recent insider transaction that took place on Sep 12 ’24, was worth 3,221,340. In this transaction EVP and Chief Clinical Officer of this company sold 8,358 shares at a rate of $385.42, taking the stock ownership to the 29,678 shares. Before that another transaction happened on Sep 12 ’24, when Company’s Officer proposed sale 8,358 for $385.42, making the entire transaction worth $3,221,340.
HCA Healthcare Inc (HCA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 16.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.00% during the next five years compared to 12.21% growth over the previous five years of trading.
HCA Healthcare Inc (NYSE: HCA) Trading Performance Indicators
Take a look at HCA Healthcare Inc’s (HCA) current performance indicators. Last quarter, stock had a quick ratio of 1.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.33. Likewise, its price to free cash flow for the trailing twelve months is 15.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 22.28, a number that is poised to hit 6.18 in the next quarter and is forecasted to reach 24.78 in one year’s time.
Technical Analysis of HCA Healthcare Inc (HCA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.26 million. That was better than the volume of 1.17 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 13.01%. Additionally, its Average True Range was 9.45.
During the past 100 days, HCA Healthcare Inc’s (HCA) raw stochastic average was set at 51.69%, which indicates a significant increase from 18.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.47% in the past 14 days, which was higher than the 27.23% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $391.90, while its 200-day Moving Average is $343.43. However, in the short run, HCA Healthcare Inc’s stock first resistance to watch stands at $368.36. Second resistance stands at $370.05. The third major resistance level sits at $372.85. If the price goes on to break the first support level at $363.86, it is likely to go to the next support level at $361.05. Assuming the price breaks the second support level, the third support level stands at $359.36.
HCA Healthcare Inc (NYSE: HCA) Key Stats
The company with the Market Capitalisation of 92.87 billion has total of 253,297K Shares Outstanding. Its annual sales at the moment are 64,968 M in contrast with the sum of 5,242 M annual income. Company’s last quarter sales were recorded 17,487 M and last quarter income was 1,270 M.
